Journal Logo

Publication Only: Chronic myeloid leukemia – Clinical

PB1927 BCR-ABL1/ABL REDUCTION RATIO SUPERIORITY OVER EMR AND HALVING TIME AS A PREDICTOR FOR OUTCOME IN EGYPTIAN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS

Elbogdady, M.1; Shamaa, S.1; Azmy, E.1; Abozeid, T.1; AbdElmoety, M.2; Emara, Z.3

Author Information
doi: 10.1097/01.HS9.0000566204.97363.f2
  • Free

Abstract

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.